Have Aspen Neuroscience insiders bought shares recently?

Yes. Insiders of Aspen Neuroscience (ASPE) filed 6 open-market purchases in the last 90 days; the latest was filed on Nov 4, 2026.

How often do Aspen Neuroscience insiders buy and sell shares?

Since 2026, Aspen Neuroscience insiders reported 6 open-market purchases and 0 sales on Forms 4 and 5, with purchases in 1 different year, most recently 2026.

Who is selling Aspen Neuroscience stock?

No open-market sale by an insider of Aspen Neuroscience (ASPE) was filed with the SEC in the last 90 days.

Do members of Congress trade ASPE?

No trade in Aspen Neuroscience (ASPE) was disclosed by a member of Congress in the last 12 months.

Where does this data come from?

From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.

Aspen Neuroscience (ASPE) insider trading and stock trades

OQRO

Ask OQRO about this page

Ask

Want the short version?

Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.

Explain this page What did insiders at ASPE buy and sell in the last 90 days?Which members of Congress and which funds traded ASPE recently?

Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.

Insider open-market trades, filed in the last 90 days6 buys · 0 sales~$68M boughtInsider trades →Congress trades, disclosed in the last 90 daysNoneNo House or Senate report names this stockCongress →Fund 13F changes, last 12 monthsNoneNo followed fund reported a changeFund moves →Federal contracts starting in the last 12 monthsNoneNo award found for this companyContracts →

Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.

Pharmaceutical Preparations company based in San Diego, CA. Listed, but no annual report (10-K) filed yet under this SEC registration.

Last 12 months

Not enough history

Market value

–

No annual report yet, so no share count

Last 30 days

Written by software from the filings listed below · Nov 13, 2026

Insiders In the 30 days to Nov 13, 2026, insiders filed 6 open-market purchases (about $68M, in 4 filings, by 4 people) and 0 open-market sales. Aspen Neuroscience on OQRO

3 more points, with the facts they come from, are in OQRO Pro.

Insider buying and selling since 2026

Insiders of Aspen Neuroscience reported 6 open-market purchases and 0 sales since 2026; purchases in 2026.

Year	Bought	Sold
2026	$68M6×6 trades	—

Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.

Holders above 5%

Latest

See everything

Fund moves

13D stake

12.9%Stake

Filed 5d ago

A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.

More Official record

Fund moves

Want the short version?

Aspen Neuroscience

How this filing works

Aspen Neuroscience is in 1 disclosure basket

Last 30 days

Insider buying and selling since 2026

Holders above 5%

Latest

12.9%Stake

5.8%Stake

12.3%Stake · was 12.3%

11.2%Stake

9.9%Stake · was 9.9%

Questions about Aspen Neuroscience insider trading

Last 30 days

Insiders who traded Aspen Neuroscience

Other Pharmaceutical Preparations companies

Holders above 5%

Insider buying and selling since 2026